Clinical trial
To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet…
NCT00398294 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00398294 |
|---|---|
| Title | To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264) |
| Official title | An Open-Label, Single-Arm, Prospective Study to Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet in Patients With Hypercholesterolemia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | MK0733, simvastatin / Duration of Treatment: 12 Weeks |
| Enrollment | 30 |
| Start date | May 1, 2005 |
| Primary completion | Apr 4, 2006 |
| Completion | Apr 4, 2006 |
| First posted | Nov 10, 2006 |
| Last update posted | Aug 15, 2024 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: